West Pharmaceutical Services, Inc. (BVMF:W2ST34)
Brazil flag Brazil · Delayed Price · Currency is BRL
40.74
0.00 (0.00%)
At close: Nov 7, 2025

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Proprietary Products Revenue
2.44B2.33B
Log In
Log In
Log In
Upgrade
Contract-Manufactured Products Revenue
573.70M558.70M
Log In
Log In
Log In
Upgrade
Revenue (Total)
3.02B2.89B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Proprietary Products Operating Profit
629.80M577.80M
Log In
Log In
Log In
Upgrade
Contract-Manufactured Products Operating Profit
69.80M72.30M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-111.70M-80.20M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
587.90M569.90M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Organic Net Sales Growth
-1.50%
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.